Breo Ellipta is a prescription drug used to treat chronic obstructive pulmonary disease (COPD) in adults and asthma in adults and children ages 5 years and older. Breo Ellipta comes as a powder that ...
GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO ® ELLIPTA ® (fluticasone furoate/vilanterol [FF/VI]) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results